Elmind Capital, LP

SEC CIK: 0002052213
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overview All 13F holders of BCRX Full Q2 2026 holdings

Shares (Q2 2026): 520,000
Value: $5.20M
% of portfolio: 1.3%
Quarters held: 3; Since Q4 2025

Holdings of BCRX by Elmind Capital, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	520,000	$5.20M	1.3%	−480,000−48.0%	Reduced	Holders
Q1 2026	1,000,000	$9.52M	2.7%	−1,150,000−53.5%	Reduced	Holders
Q4 2025	2,150,000	$16.8M	4.9%	–	No prior filing	Holders